Approval · Notice of Compliance 18342 · 2016
SAPHRIS: Notice of Compliance 18342
Issued July 28, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18342
- Date
- July 28, 2016
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To incorporate data from a new safety and efficacy study into the product monograph and revise the dosing instructions
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SAPHRIS | Not yet assigned | — |